Diagnostic procedures in B19 infection

Pathologie Biologie

Volumn 50, Issue 5, 2002, Pages 332-338

  Zerbini, M ^a,b   Gallinella, G ^a   Cricca, M ^a   Bonvicini, F ^a   Musiani, M ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Parvovirus B19; Virological and serological diagnosis

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS DNA;

ANEMIA; ANTIBODY DETECTION; ARTHROPATHY; ARTICLE; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE COURSE; DNA HYBRIDIZATION; ELECTROIMMUNOASSAY; FETUS DEATH; FETUS HYDROPS; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNOCOMPETENCE; IMMUNOFLUORESCENCE; PARVOVIRUS; POLYMERASE CHAIN REACTION; PREGNANCY COMPLICATION; RASH; SERODIAGNOSIS; VIRUS DETECTION; VIRUS INFECTION; VIRUS REPLICATION;

EID: 0036081772     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0369-8114(02)00308-5     Document Type: Article

References (51)

1. Human Parvoviruses
2. Screening of blood donors for human parvovirus B19 and characterization of the results
3. Detection of antibodies and antigens of human parvovirus B19 by enzyme-linked immunosorbent assay
4. Diagnostic assays with monoclonal antibodies for the serum parvovirus-like virus (SPLV)
5. Dot immunoperoxidase assay for the detection of parvovirus B19 antigens in serum samples
6. Screening of blood donors for human parvovirus B19
7. Detection of B19 parvovirus infections by a dot blot hybridization assay using a digoxigenin-labelled probe
8. Detection of human parvovirus using a molecularly cloned probe
9. Use of M13 single stranded DNA digoxigenin labelled probe for detection of human parvovirus B19 viraemia
10. Evaluation of strand-specific RNA probes visualized by colorimetric and chemiluminescent reactions for the detection of B19 parvovirus DNA
11. A system to enhance the sensitivity of digoxigenin-labelled probe: Detection B19 DNA in serum samples
12. A simple and sensitive DNA hybridization assay used for the routine diagnosis of human parvovirus B19 infection
13. Chemiluminescence dot blot hybridization assay for detection of B19 Parvovirus DNA in human sera
14. Large-scale screening for human parvovirus B19 DNA in clinical specimens by dot blot hybridization and polymerase chain reaction
15. Rapid screening for B19 parvovirus DNA in clinical specimens with a digoxigenin-labeled DNA hybridization probe
16. Chemiluminescent microwell hybridization assay for direct detection of human parvovirus B19 DNA
17. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy
18. Synthetic oligonucleotide cocktails as probes for detection of human parvovirus B19
19. Detection of B19 Parvovirus in human fetal tissue by in situ hybridization
20. Detection of parvovirus B19 DNA in bone marrow cells by chemiluminescence in situ hybridization
21. A rapid method of sample preparation for detection of DNA viruses in human serum by polymerase chain reaction
22. Human parvovirus B19 infections: Routine diagnosis by a new nested polymerase chain reaction assay
23. Polymerase chain reaction assay of Parvovirus B19 DNA in clinical specimens
24. Multiple primer pairs for polymerase chain reaction (PCR) amplification of human parvovirus B19 DNA
25. Detection of human parvovirus B19 DNA by using the polymerase chain reaction
26. Nested polymerase chain reaction assay for the detection of B19 parvovirus DNA in human immunodeficiency virus patients
27. Characterization of a nested polymerase chain reaction assay for detection of Parvovirus B19
28. Detection of human parvovirus B19 DNA PCR products by RNA probe hybridization enzyme immunoassay
29. Quantitation of parvovirus B19 DNA sequences by competitive PCR: Differential hybridization of the amplicons and immunoenzymatic detection on microplate
30. Development of a chemiluminescence competitive PCR for the detection and quantification of Parvovirus B19 DNA using a microplate luminometer
31. A quantitative, internally controlled real-time PCR Assay for the detection of parvovirus B19 DNA
32. Quantitation of viral DNA by real-time PCR applying duplex amplification, internal standardization, and two-color fluorescence detection
33. An immunofluorescence assay for the detection of parvovirus B19 IgG and IgM antibodies based on recombinant viral antigen
34. Self assembled B19 parvovirus capsids, produced in a baculovirus system, are antigenically and immunogenically similar to native virions
35. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG
36. Prokariotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyne immunoassay
37. Chemiluminescence western blot assay for the detection of immunity against parvovirus B19 VP1 and VP2 linear epitopes using a videocamera based luminograph
38. Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans
39. Expression of the human parvovirus B19 protein fused to protein A in Escherichia coli. Recognition by IgM and IgG antibodies in human sera
40. Epitope type-specific IgG responses to capsid proteins VP1 and VP2 of human parvovirus B19
41. IgG response to the immunoreactive region of parvovirus B19 nonstructural protein by immunoblot assay with a recombinant antigen
42. Antibodies to parvovirus B19 NS-1 protein in infected individuals
43. Seroprevalence of parvovirus B19 NS1-specific IgG in B19-infected and uninfected individuals and in infected pregnant women
44. Antibodies to parvovirus B19 non-structural protein are associated with chronic but not acute arthritis following B19 infection
45. Detection of parvovirus B19-specific IgM by antibody capture radioimmunoassay
46. Human parvovirus B19, ELISA immunoblot assay
47. Comparison of a baculovirus-based VP2 enzyme immunoassay (EIA) to an Escherichia coli-based VP1 EIA for detection of human parvovirus B19 immunoglobulin M and immunoglobulin G in sera of pregnant women
48. Differential IgM reponse to conformational and linear epitopes of parvovirus B19 VP1 and VP2 structural proteins
49. Antigenic parvovirus B19 coat proteins VP1 and VP2 produced in large quantities in a baculovirus expression system
50. Antibody response to human parvovirus B19 in patients with primary infection by immunoblot assay with recombinant proteins
51. Development and evaluation of capture immunoglobulin G and M hemadherence assay using human type erythrocytes and recombinant parvovirus B19 antigen